Apolipoprotein E polymorphism in various dementias in Taiwan Chinese population

Journal of Neural Transmission

Volumn 109, Issue 11, 2002, Pages 1415-1421

  Huang, H M ^a   Kuo, Y M ^b   Ou, H C ^a   Lin, C C ^a   Chuo, L J ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; Apolipoprotein E; Dementia; Polymorphism

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR DISEASE; CHINESE; CONTROLLED STUDY; DEMENTIA; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; SENILE DEMENTIA; TAIWAN; ALLELE; ASIAN; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DEMENTIA; DEMENTIA, VASCULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; TAIWAN;

EID: 0036832827     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-002-0751-2     Document Type: Article

References (34)

1. Blacker D, Haines JL, Rodes L, Terwedow H, Go RC, Harrell LE, Perry RT, Bassett SS, Chase G, Meyers D, Albert MS, Tanzi R (1997) ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology 48: 139-147
2. Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RC, Perry R, Watson B Jr, Bassett SS, McInnis MG, Albert MS, Hyman BT, Tanzi RE (1998) α-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 9: 357-360
3. Centers for Disease Control and Prevention. In: Leading Causes of Death Reports [online]. Available at: http://webapp.cdc.gov/sasweb/ncipc/leadcaus.html (accessed June 2, 2001)
4. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
5. Crawford FC, Freeman MJ, Schinka JA, Abdullah LI, Gold M, Hartman R, Krivian K, Morris MD, Richards D, Duara R, Anand R, Mullan MJ (2000) A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease. Neurology 55: 763-768
6. Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arterioscler 8: 1-21
7. Hixon JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-548
8. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 349: 151-154
9. Hu CJ, Sung SM, Liu HC, Chang JG (1998) Association of apolipoprotein E genotype and intronic polymorphism of the presenilin-1 gene with Alzheimer's disease in elderly Taiwan Chinese. J Neurol Sci 157: 158-161
10. Ji Y, Urakami K, Adachi Y, Maeda M, Isoe K, Nakashima K (1998) Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Dement Geriatr Cogn Disord 9: 243-245
11. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST (1995) APOE4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nat Genet 10: 486-488
12. Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J (1994) Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry 57: 1414-1416
13. Kehoe PG, Williams H, Holmans P, Wilcock G, Cairns NJ, Neal J, Owen MJ (1998) The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease. J Med Genet 35: 1034-1035
14. Ki CS, Na DL, Kim JW, Kim HJ, Kim DK, Yoon BK (1999) No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease. Am J Med Genet 88: 113-115
15. Kim HS, Kamboh MI (1998) Genetic polymorphisms of apolipoproteins A-IV, E and H in Koreans. Hum Hered 48: 313-317
16. Lendon CL, Talbot CJ, Craddock NJ, Han SW, Wragg M, Morris JC, Goate AM (1997) Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett 222: 187-190
17. Licastro F, Pedrini S, Ferri C, Casadei V, Govoni M, Pession A, Sciacca FL, Veglia F, Annoni G, Bonafe M, Olivieri F, Franceschi C, Edoardo Grimaldi LM (2000) Gene polymorphism affecting α1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann Neurol 48: 388-391
18. Liu HC, Lin KN, Teng EL, Wang SJ, Fuh JL, Guo NW, Chou P, Hu HH, Chiang BN (1995) Prevalence and subtypes of dementia in Taiwan: a community survey of 5,297 individuals. J Am Geriatr Soc 43: 144-149
19. Liu CK, Lin RT, Chen YF, Tai CT, Yen YY, Howng SL (1996) Prevalence of dementia in an urban area in Taiwan. J Formos Med Assoc 95: 762-768
20. Meyer MR, Tschanz JT, Norton MC, Welsh-Bohmer KA, Steffens DC, Wyse BW, Breitner JC (1998) APOE genotype predicts when - not whether - one is predisposed to develop Alzheimer disease. Nat Genet 19: 321-322
21. Morris JC (1997) Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 9 [Suppl 1]: 173-176
22. Mui S, Briggs M, Chung H, Wallace RB, Gomez-Isla T, Rebeck GW, Hyman BT (1996) A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele. Neurology 47: 196-201
23. Myers RH, Schaefer EJ, Wilson PW, D'Agostino R, Ordovas JM, Espino A, Au R, White RF, Knoefel JE, Cobb JL, McNulty KA, Beiser A, Wolf PA (1996) Apolipoprotein E ε4 association with dementia in a population-based study: the Framingham study. Neurology 46: 673-677
24. National Institutes of Health (1998) In: Progress report on Alzheimer's disease. National Institutes of Health, Bethesda, pp 2-3
25. Ordovas JM, Litwack-Klein L, Wilson PW, Schaefer MM, Schaefer EJ (1987) Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res 28: 371-380
26. Papassotiropoulos A, Bagli M, Feder O, Jessen F, Maier W, Rao ML, Ludwig M, Schwab SG, Heun R (1999) Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease. Neurosci Lett 262: 171-174
27. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11: 575-580
28. Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT (1994) Reduced apolipoprotein ε4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 44: 1513-1516
29. Roses AD (1996) Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 47: 387-400
30. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472
31. Skoog I, Kalaria RN, Breteler MM (1999) Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord 13 [Suppl 3]: S106-S114
32. Slooter AJ, Tang MX, van Duijn CM, Stern Y, Ott A, Bell K, Breteler MM, Van Broeckhoven C, Tatemichi TK, Tycko B, Hofman A, Mayeux R (1997) Apolipoprotein E ε4 and the risk of dementia with stroke. A population-based investigation. JAMA 277: 818-821
33. Tsuda T, Lopez R, Rogaeva EA, Freedman M, Rogaev E, Drachman D, Pollen D, Haines J, Liang Y, McLachlan DR, Duara R, St. George-Hyslop P (1994) Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium? Ann Neurol 36: 97-100
34. Weisgraber KH, Mahley RW (1996) Human apolipoprotein E: the Alzheimer's disease connection. FASEB J 10: 1485-1494